E-mails Question FDA Review Process For Ketek
Several recently uncovered e-mails have exposed concern by Food and Drug Administration officials that the agency's approval of a bronchitis treatment marketed by Sanofi-Aventis was a potentially lethal mistake....To view the full article, register now.
Already a subscriber? Click here to view full article